GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Other Stockholders Equity

Y-Biologics (XKRX:338840) Other Stockholders Equity : ₩7,617 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Other Stockholders Equity?

Y-Biologics's Other Stockholders Equity for the quarter that ended in Mar. 2024 was ₩7,617 Mil.

Y-Biologics's quarterly Other Stockholders Equity increased from Sep. 2023 (₩6,624 Mil) to Dec. 2023 (₩7,149 Mil) and increased from Dec. 2023 (₩7,149 Mil) to Mar. 2024 (₩7,617 Mil).

Y-Biologics's annual Other Stockholders Equity increased from Dec. 2020 (₩2,320 Mil) to Dec. 2021 (₩3,186 Mil) and increased from Dec. 2021 (₩3,186 Mil) to Dec. 2022 (₩5,741 Mil).

Y-Biologics Other Stockholders Equity Historical Data

The historical data trend for Y-Biologics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Other Stockholders Equity Chart

Y-Biologics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Stockholders Equity
Get a 7-Day Free Trial 820.65 1,197.16 2,320.28 3,186.44 5,740.61

Y-Biologics Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only 6,236.50 6,554.88 6,624.05 7,149.01 7,616.98

Y-Biologics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Y-Biologics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Y-Biologics (XKRX:338840) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Other Stockholders Equity
Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR
Website
https://www.ybiologics.com
Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics (XKRX:338840) Headlines

No Headlines